Kangmei Pharma | 600518 - Debt


Kangmei Pharma reported CNY173.71M in Debt for its fiscal quarter ending in March of 2026.





Debt Change Date
Akebia Therapeutics USD 46.51M 7.82M Mar/2025
Alaunos Therapeutics USD 10.99M 5.78M Mar/2023
Avita Medical AUD 46.05M 1.46M Dec/2025
Cspc Pharmaceutical CNY 495M 12.33M Jun/2025
Dianthus Therapeutics USD 1.28M 45K Sep/2025
Genomma Lab Internacional MXN 8.06B 488.83M Mar/2026
Hypermarcas BRL 8.86B 535.71M Jun/2025
Ionis Pharmaceuticals USD 2.34B 9.5M Mar/2026
IQVIA Holdings USD 15.83B 109M Mar/2026
Jiangsu Hengrui CNY 74.23M 17.2M Dec/2025
Kangmei Pharma CNY 173.71M 42.08M Mar/2026
Moderna USD 1.31B 571M Dec/2025
Organon & Co USD 8.64B 184M Dec/2025
Revvity USD 3.4B 29.2M Dec/2025
Sh Fosun Pharma CNY 38.09B 1.1B Dec/2025
Tectonic Therapeutic USD 876K 115K Dec/2024
Viatris USD 14.34B 69.3M Mar/2026
Wuxi Apptec CNY 8.38B 41.18M Mar/2026
Xeris Pharmaceuticals USD 257.65M 431K Sep/2025
Zz Pientze Pharmaceu CNY 1.07B 2.82M Mar/2026